Prehospital Thrombolysis for AMI to be Studied in New Clinical Trial / Study will investigate concept that prehospital lysis can be at least as good as primary PCI
Ingelheim, Germany (ots) - For scientific media outside the USA, Canada and Japan Boehringer Ingelheim announced today that it is undertaking a new initiative in the treatment of heart attack (ST-segment elevation myocardial infarction or STEMI). The company will sponsor a new clinical trial known as ...
mehr